Repertoire Immune Medicines
Cambridge
About Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company working to unleash the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $257.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2021)
- Website: repertoire.com
- Phone: (617) 863-3650
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/repertoire-immune-medicines-27232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.